Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Infectious Disorders Drug Targets|October 15, 2025
Strategic Directions for Addressing Human Metapneumovirus (HMPV) in IndiaMansi Singh, Sanjesh KumarCurrent Gene Therapy|March 12, 2026
Molecular Complexities of Dementia: PAISA Mutations and Targeting TAF2N as Therapeutic AvenuesSiva Prasad Panda, Sanjesh Kumar, Mansi Singh, et al.Fitoterapia|August 8, 2024
Limonin (LM) and its derivatives: Unveiling the neuroprotective and anti-inflammatory potential of LM and V-A-4 in the management of Alzheimer's disease and Parkinson's diseaseSiva Prasad Panda, Adarsh Kesharwani, Mansi Singh, et al.Indian Economic Review|May 24, 2021
COVID-19: facts, figures, estimated relationships and analysisRanjan Ray, Sanjesh KumarEconomics and Human Biology|February 2, 2025
Smoking to your kids gain? Childhood exposure to parental smoking and obesityKushneel Prakash, Sanjesh KumarCurrent Molecular Medicine|October 25, 2023
Targeting GM2 Ganglioside Accumulation in Dementia: Current Therapeutic Approaches and Future DirectionsSanjesh Kumar, Siva Prasad PandaCurrent Computer-Aided Drug Design|February 4, 2024
Comprehensive In Silico Analysis of Uncaria Tomentosa Extract: Chemical Profiling, Antioxidant Assessment, and CLASP Protein Interaction for Drug Design in Neurodegenerative DiseasesSanjesh Kumar, Siva Prasad PandaMedical Oncology (Northwood, London, England)|May 15, 2025
Natural sesquiterpene lactones in prostate cancer therapy: mechanisms and sourcesKeshav Kaushal, Devesh U Kapoor, Sanjesh Kumar, et al.Biochemical Pharmacology|February 8, 2025
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer's disease and Parkinson's disease: Therapeutic avenue of Dual OXR Antagonist (DORA)Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.Plos One|July 24, 2020
The economic burden of non-communicable disease mortality in the South Pacific: Evidence from FijiShamal Shivneel Chand, Baljeet Singh, Sanjesh KumarPageof 7